The morbid anatomical changes seen in the colon of 12 purgative addicts consisted of three main features: loss of the intrinsic innervation, atrophy of the smooth muscle coats and melanosis coli.
Most of the patients coming to colectomy for this condition have been taking purgatives for 30-40 years. A large number of the myenteric neurones are lost, with Schwann cell proliferation in the ganglia, the remaining neurones being dark and shrunken with clubbed processes. Two of the 12 cases were under 30 when they had the colon removed, and therefore had a much shorter history. The myenteric plexus in these cases showed a number of pale, enormously swollen but otherwise normal neurones. Extrapolating from animal material, this is the appearance of a grossly overstimulated cell. It suggests that the initial action of the purgative is to stimulate neurones, but that over the course of years they tire and eventually die.
Surgeons who have operated on these cases know that the bowel is thin and baggy. The transverse colon is often pendulous and there is a large dilated sigmoid. The muscle coats in these cases are thin and this can be seen macroscopically and microscopically. It is not just due to dilatation because the physiological response of smooth muscle to stretch and denervation is not atrophy but hypertrophy, as is shown well in Chagas' disease. Another feature seen in 5 out of 12 cases is the presence of excess adipose tissue in the submucous layer. This was described by Morson (Jones 1967) and might also suggest that there is some tissue loss.
Melanosis coli is diagnostic of purgative taking and consists of pigment-containing macrophages in the mucosa. Special stains of this pigment show that it is not melanin but has many of the staining reactions of lipofuscin, a wear-and-tear pigment. It is very likely to be a combination of a pigment of this type with either anthraquinone or one of its breakdown products.
Anthraquinones given parenterally are extremely potent cell poisons even in minute doses. However, it is apparent that the vegetable products of cascara and senna which have been in use for centuries are quite safe. People dying from purgative addiction die from the metabolic side-effects, not anthraquinone poisoning. There are probably two reasons for this. One is that very little of the active principle is absorbed at all, and the other is that much of what is absorbed is concentrated in the colon, mainly on the right side. Like many neurotoxins, including cyanide and strychnine, they probably stimulate nervous tissue in small quantities, hence the purgative action.
Since they are cell poisons they produce a progressive destruction of the tissue in which they are concentrated, the colon. They affect first the most sensitive cells, the neurones, but later the smooth muscle also suffers damage. Finally, the colon is destroyed as a functioning organ and the surgeon has little alternative but to remove it. An additional problem is that, as this is mainly a disease of the right side, sigmoid colectomy may not prove a permanent answer.
The vegetable laxatives of known safety are considered by the pharmaceutical industry to be too cheap and simple. The anthraquinone derivatives are now being marketed as pure substances, often together with other drugs given to enhance their absorption. As expected, since they are cell poisons, this makes them much more toxic. For two products on the market in this country, the lethal (not the toxic) dose, extrapolated from animal experimnents, is only eight times the recommended dose. These drugs may be bought across the counter by patients who tend to take more than the stated dose anyway, and some of whom are psychologically disturbed.
(This work will be published more fully in the Journal ofPathology.] Purgatives are amongst the most widely used and abused of drugs. In considering some of the effects of chronic purgative ingestion, it is helpful to classify these drugs according to their mechanism of action, as follows:
Lubricants: Liquid paraffin, dioctyl sodium sulphosuccinate.
Bulk additives: Agar, methylcellulose. Osmotic cathartics: (1) Unabsorbed salts; magnesium sulphate, sodium sulphate. (2) Other solutes, e.g. lactulose. 'Irritant' cathartics: Anthraquinones (rhubarb, senna, aloes, cascara). Phenolphthalein and derivatives, e.g. oxyphenisatin, bisacodyl (Dulcolax).
The modes of action of the lubricant and bulk purgatives are self-explanatory and their effects are generally so mild that they are unlikely to satisfy the determined patient for any length of time. The osmotic cathartics are poorly absorbed solutes, which retain an osmotically appropriate volume of fluid in the gut lumen. This takes place predominantly in the permeable upper small intestine (Fordtran et al. 1965) and results in the rapid transit of small gut contents into the colon, whose absorptive capacity can be relatively easily overwhelmed (Shields & Miles 1965) . If taken in sufficient dosage, the saline cathartics will cause profuse diarrheea of rapid onset. For this reason they ara seldom taken regularly as the sole laxative. Lactulose is an unabsorbed disaccharide currently recommended as a treatment for chronic portal-systemic encephalopathy (Elkington 1970) . It is dispensed in liquid form and is too inconvenient and expensive to be taken regularly for its purgative effects.
The majority of purgative users consume one or several of the irritant cathartics. These drugs are generally considered to have a direct effect on gut motility, especially on the colon (e.g. Hardcastle & Mann 1968 ) and they probably act primarily on the myenteric plexus (Smith 1968 ). There is also evidence that some of these drugs inhibit mucosal transport processes acutely in both small and large intestine (Table 1) . Forth et al. (1966) found that bisacodyl preparations had a quantitatively far greater effect on colonic than on small gut transport. The combination of increased colonic motility and reduced colonic absorption of water and sodium would allow small intestinal contents to pass to the rectum relatively unaltered in composition and volume. Over the years, increasing quantities of these drugs may be required in order to maintain effective purgation. This may be the result of gradual destruction of the myenteric plexus with the conversion of the colon into an inert tube. Alternatively, the patient complains ofdiarrhoea and may then deny the consumption ofpurgatives. Surreptitious purgative abuse must always be remembered as a possible cause of 'functional diarrhoea'. Routine investigations are often normal, but there may be hypokalmmia and the barium enema may show some features of the so-called 'cathartic colon' (Rawson 1966) . In a severe case, the colon is dilated and featureless and often has characteristic pseudostrictures. These changes suggest prolonged consumption of purgatives, with gross damage to the myenteric plexus, but may be reversible. The appearances can resemble those of ulcerative colitis, but this diagnosis is excluded by the essentially normal sigmoidoscopic appearances. A positive diagnosis may be suggested by the mucosal pigmentation which often accompanies prolonged consumption of drugs of the anthraquinone class.
A most useful screening test for surreptitious consumption ofphenolphthalein-containing drugs is that addition of alkali to the stool, and often the urine, produces a deep red colour. This may become apparent during the estimation of fecal fat by the standard van de Kamer technique (French et al. 1956 ), but should be used as a simple test. Certain dietary items, such as rhubarb, may produce a red discoloration of stools. Phenolphthalein should be identified by spectrophotometric analysis of an alcoholic extract of stool before confronting the patient with the diagnosis.
There are no other satisfactory and simple screening tests for purgatives, and the suspicious clinician must endeavour to find the offending drug by all means at his disposal.
(2) General: Patients may occasionally deny both diarrheea and the consumption of laxatives and present with a variety of baffling symptoms caused by the metabolic consequences ofpurgative abuse. The most characteristic is muscular weakness, which may be profound and accompanied by gross hypokalmmia. This usually responds promptly to adequate potassium replacement, but sometimes this may be difficult to achieve if its cause goes unrecognized. In some cases, hypokalkmia has suggested a 13 289 290 Proc. roy. Soc. Med. Volume 65 March 1972 diagnosis of aldosteronism and has responded to the antagonist spironolactone (e.g. Fleischer et al. 1969 ). As will be discussed later, secondary aldosteronism may play an important role in the development of potassium deficiency in such patients. Thirst is often reported in the literature and may be difficult to quench. It may be the result of simple sodium and water loss in the stools, but may also be a consequence of the impaired renal function that often accompanies potassium deficiency. It is now generally accepted that potassium deficiency can lead to impaired renal conservation ofwater (Schwartz & Rellman 1953) .
Tetany is sometimes described and is usually associated with both hypocalcwmia and alkalosis. The exact mechanism of the hypocalcamia is not clear, although it is generally attributed to the mild steatorrhoea which may accompany laxative abuse (French et al. 1956 , Coghill et al. 1959 ). The alkalosis is usually the result of potassium deficiency and will respond to adequate replacement therapy.
Finally, patients may present with a combination of all these features, accompanied by severe dehydration and gross weight loss. Such a condition may prove fatal, even if its cause is promptly recognized and the deficiencies rapidly corrected.
Electrolyte Losses in Diarrhawal States
The most characteristic metabolic consequence of purgative abuse is potassium deficiency and this applies to any chronic diarrhoeal illness. In order to understand the mechanism ofthis, it is necessary to consider the electrolyte composition of stools. In normal subjects, the potassium concentration of stool fluid exceeds that of sodium (Wrong et al. 1965) , whereas sodium predominates in ileal fluid (Kanaghinis et al. 1963 ). In diarrhoeal states, with daily stool volumes of up to 1 litre, there is a reciprocal alteration of cation concentration with increasing stool flow (Fig 1) . This means that sodium losses will increase considerably with increasing fluid loss, whereas potassium losses are smaller and less affected by the magnitude of stool flow (Fig 2) . This relationship also applies at higher rates of stool flow (reviewed by Fordtran & Dietschy 1966) and, indeed, if the flow exceeds 3 litres in 24 hours, the stool composition resembles that of normal ileal fluid very closely. In patients with chronic purgative abuse it would be uncommon for daily stool volumes to exceed 1 litre. Thus, daily potassium losses would not be expected to exceed approximately 25 mEq, compared with a normal range of 10-20 mEq (Wilson 1962 ). (1965) . Each point represents the mean concentrationfrom at least three 24-hour stool collections in an individual subject. Framedpoints refer to one subject, believed to showfeatures of secondary aldosteronism (see text). Dotted lines represent approximate correlations drawn by eye. Stoolfluid was obtained by a technique similar to that of Wrong et al. (1965) Aldosterone is known to increase the potassium concentration in normal stool and ileal fluid (Goulston et al. 1963 , Charron et al. 1969 ). This may also apply to patients with a variety of diarrhoeal illnesses and a single example is shown in Figs 1 and 2. This patient had Crohn's disease and the nephrotic syndrome and demonstrated avid renal retention of sodium, presumably related to secondary aldosteronism. There are no detailed studies on the effects of aldosterone and its antagonists on the electrolyte composition of stools in patients with various types of diarrheea. Nevertheless, diarrhoea may lead to chronic sodium depletion with the development of secondary aldosteronism. Renal conservation of sodium may be adequate to maintain sodium balance and normal hydration, but potassium loss from both the gut and the kidney would be increased. This probable sequence of events is well illustrated by the cases described in the papers of Wolff et al. (1968) and Fleischer et al. (1969) .
The role of aldosterone in the development of potassium deficiency in patients with chronic purgative abuse must remain somewhat speculative. There is evidence from animal studies that certain purgatives increase colonic secretion of potassium (Forth et al. 1966 ), but the mechanism is obscure. The direct effects, if any, of purgatives on the transport of water and electrolytes by the normal human colon have not been reported.
Conclusions
It is evident that the chronic consumption of purgatives can lead to a variety of serious organic disturbances. Recognition of the nature of the problem by the clinician may be an easy matter, once his suspicion is aroused. However, in most, if not all, of these patients there is an underlying personality disorder. It is often difficult, and may be impossible, to wean the patient off purgatives and to restore a normal bowel habit even when the colon is not irreversibly damaged. Furthermore, especially if the purgative abuse is surreptitious, confrontation of the patient with the truth may produce serious psychiatric problems and should be undertaken with circumspection. The combined efforts of family doctor, hospital clinician and psychiatrist are often required in the effective management of these unfortunate patients. Although the use of azathioprine as a possible treatment for Crohn's disease has been widely discussed, there are few reported series. Brooke et al. (1970 ), Druker & Jeejeebhoy (1970 , Brown (1970 ), Arden Jones (1971 and Patterson et al. (1971) report encouraging results with this treatment in a total of 74 patients, but the preliminary results of a double blind trial (Rhodes et al. 1970) have not given evidence of benefit.
During the last six years azathioprine has been used in the treatment of 40 patients with Crohn's disease at St Mark's Hospital. This report considers 22 patients treated with the drug for over three months and 3 other cases where the drug had to be withdrawn because of side-effects. Patients given azathioprine for less than three months are not considered because of difficulty in assessing its effect. The patients were highly selected, 17 of 25 being referred after failure of treatment at other hospitals and 13 of 25 having primarily anal or perineal Crohn's disease. Most of them were taking other medication and azathioprine was always used after failure of other treatment and in the most severe cases. A standard dose regime of 2-2 5 mg/kg body weight was used; in the majority a dose of 4 mg/kg was given for the first ten days of treatment. Blood counts (hlemoglobin, total white blood count and platelets) were performed twice weekly for a month, then weekly for two months, fortnightly for two months and monthly thereafter. There have been no hematological side-effects over a total of 31 patient years of azathioprine treatment, and no white cell count has fallen below 3,500/mm3.
Results
The 25 patients have been divided on overall clinical grounds into four groups: 'improved', 'no improvement', 'side-effects' and 'uncertain'. No single criterion of assessment or group of criteria could be applied to all patients, a difficulty which is likely to arise in any treatment trials in Crohn's disease. 'Improved' (9 patients): These were unexpectedly well after treatment. The group includes patients with disease in different sites from the ileum to the perineum, and the mean tteatment time was seventeen months for each patient.
